Medical Research
(H41)
990 on File
A RACE AGAINST BLINDNESS
Financial strength (30%)
41/100
Reliability (20%)
40/100
Effectiveness (25%)
41/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$12.5M
Total Revenue
$11.7M
Total Expenses
$920K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
25.9%
Fundraising Efficiency
N/A
Operating Reserve
0.94x
Liability-to-Asset
14.0%
Revenue Diversification
111.8%
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
25.9% | 82.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.8% | 12.7% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
72.3% | 0.7% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.9 mo | 14.5 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
14.0% | 21.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
111.8% | 90.8% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
6541.9% | 9.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
5.9% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $12.5M | $11.7M | $920K | 25.9% | 0 |
| 2023 | $188K | $0 | $188K | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.